Skip to main content
    S

    Schrodinger Inc (SDGR)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $25.89
    -0.02 (-0.08%)

    Market Cap: $1.87B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    41%(11/27)
    Avg Surprise
    -23.97%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.52
    Range$-0.52 - $-0.52
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.61+14.8%
    60d ago$-0.61+14.8%
    30d ago$-0.64+18.8%
    7d ago$-0.64+18.8%
    Current$-0.52
    Revenue Consensus
    $49M
    Range$35M - $55M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.07
    Range$-0.07 - $-0.07
    1 analysts
    Revenue Consensus
    $99M
    Range$80M - $119M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.07---
    Sep 26EST
    		-$-0.52---
    Jun 26
    Reported Aug 5
    		$0.08N/A+113.33%Beat+112.3%
    Mar 26
    Reported May 5
    		$-0.62$-0.57-8.77%Miss+3.1%
    Dec 25
    Reported Feb 25
    		$-0.18$-0.20+7.59%Beat+24.9%
    Sep 25
    Reported Nov 5
    		$-0.45$-0.75+40.00%Beat+48.3%
    Jun 25
    Reported Aug 6
    		$-0.65$-0.64-1.56%Miss+12.2%
    Mar 25
    Reported May 7
    		$-0.64$-0.81+20.99%Beat+15.8%
    Dec 24
    Reported Feb 26
    		$-0.24$-0.38+36.84%Beat+41.5%
    Sep 24
    Reported Nov 12
    		$-0.87$-0.63-38.10%Miss-24.3%
    Jun 24
    Reported Jul 31
    		$-0.74$-0.89+16.85%Beat-23.3%
    Mar 24
    Reported May 1
    		$-0.76$-0.74-2.70%Miss-230.4%
    Dec 23
    Reported Feb 28
    		$-0.41$-0.38-7.89%Miss-7.9%
    Sep 23
    Reported Nov 1
    		$-0.70$-0.69-1.45%Miss-40.0%
    Jun 23
    Reported Aug 2
    		$-0.60$-0.38-57.89%Miss-252.9%
    Mar 23
    Reported May 4
    		$-0.23$-0.19-21.05%Miss+14.8%
    Dec 22
    Reported Feb 28
    		$-0.38$-0.53+28.30%Beat+11.6%
    Sep 22
    Reported Nov 3
    		$-0.50$-0.59+15.25%Beat-31.6%
    Jun 22
    Reported Aug 4
    		$-0.17N/A+65.31%Beat+46.9%
    Mar 22
    Reported May 4
    		$-0.27$-0.43+37.21%Beat+0.0%
    Dec 21
    Reported Feb 24
    		$-0.43$-0.39-10.26%Miss-138.9%
    Sep 21
    Reported Nov 10
    		$-0.38$-0.29-31.03%Miss-72.7%
    Jun 21
    Reported Aug 12
    		$-0.32$-0.09-255.56%Miss-28.0%
    Mar 21
    Reported May 11
    		$-0.27$-0.25-8.00%Miss-22.7%
    Dec 20
    Reported Mar 4
    		$-0.18$-0.08-125.00%Miss+83.8%
    Sep 20
    Reported Nov 12
    		$-0.22$-0.09-144.44%Miss-2100.0%
    Jun 20
    Reported Aug 10
    		$-0.25$-0.32+21.88%Beat-
    Mar 20
    Reported May 13
    		$-0.22$-0.20-10.00%Miss-
    Dec 19
    Reported Mar 16
    		$-1.11$-0.26-326.92%Miss-
    Sep 19
    Reported Oct 30
    		$-0.01$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-22.12EV/EBITDAN/A
    Price/FCF-14.85xFCF Yield-6.73%
    Profitability
    Profit Margin-21.00%Operating Margin-70.60%
    ROE-16.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.71xQuick Ratio2.71x
    Trading Statistics
    Beta1.62Avg Volume3.36M
    52-Week High$33.7852-Week Low$10.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$28.61
    SMA 20$28.88
    SMA 50$23.07
    SMA 200$16.30
    EMA 10$27.63
    EMA 20$27.23
    EMA 50$24.00
    EMA 200$18.85

    MACD

    Line: 1.13Signal: 1.99Hist: -0.86

    ADX

    ADX: 40.0+DI: 26.4-DI: 20.0

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down12.0
    PSAR$32.02

    Bollinger Bands

    Upper Band$33.15
    Lower Band$24.61
    %B Position2957%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    48.0

    Momentum Oscillators

    Stoch %K10.5
    Stoch %D11.1
    Williams %R-94.3
    ROC (10d)-14.6%
    Momentum-4.44
    CCI (20d)-119.2
    MFI (14d)35.5

    Volatility Measures

    ATR (14d)$2.00(7.7%)
    StdDev (20d)2.13
    Hist Vol117.6%(High)

    Volume Flow

    VWAP$25.87
    OBV7.2M
    AD Line-2.4M
    CMF (20d)0.024

    Volume Metrics

    Avg Vol (20d)3.4M
    Vol Ratio0.4x(Low)
    VWMA (20d)$29.23

    Pivot Points

    R3$29.24
    R2$28.38
    R1$27.14
    Pivot Point$26.28
    S1$25.04
    S2$24.18
    S3$22.94

    Advanced Oscillators

    TSI15.43
    Ultimate Osc41.5
    KST377.43

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$58.89M$58.59M$87.23M$54.32M$54.76M$59.55M$88.32M$35.29M$47.33M$36.60M$74.13M$42.57M
    Cost of Revenue$26.46M$29.04M$29.94M$26.29M$28.60M$28.43M$24.19M$17.56M$16.00M$17.71M$16.58M$18.93M
    Gross Profit$32.43M$29.55M$57.29M$28.04M$26.16M$31.12M$64.13M$17.73M$31.34M$18.89M$57.55M$23.64M
    Operating Expenses$73.98M$78.34M$74.45M$73.99M$79.06M$82.01M$84.84M$86.15M$84.06M$86.32M$87.17M$79.83M
    R&D$41.00M$43.82M$41.40M$42.76M$43.14M$45.84M$49.36M$50.98M$50.84M$50.61M$51.49M$46.83M
    SG&A$22.71M$22.91M$22.71M$21.70M$25.19M$25.80M$25.78M$24.82M$23.54M$25.54M$25.73M$23.89M
    Operating Income$-41,547,000$-48,794,000$-17,157,000$-45,947,000$-52,903,000$-50,889,000$-20,712,000$-68,422,000$-52,729,000$-67,433,000$-29,621,000$-56,193,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$-109,000$0
    Interest Expense$0$10.82M$0$0$0$8.89M$18.54M$0$1.24M$0$1.89M$8.72M
    Income Before Tax$7.35M$-59,618,000$32.97M$-32,633,000$-42,886,000$-59,780,000$-39,253,000$-38,226,000$-53,964,000$-54,268,000$-31,512,000$-64,911,000
    Income Tax Expense$1.37M$408,000$462,000$162,000$287,000$28,000$963,000$-90,000$83,000$456,000$-842,000$-2,887,000
    Net Income$5.97M$-60,026,000$32.51M$-32,795,000$-43,173,000$-59,808,000$-40,216,000$-38,136,000$-54,047,000$-54,724,000$-30,670,000$-62,024,000
    EBITDA$9.29M$-58,806,000$34.89M$-31,839,000$-42,170,000$-59,052,000$-38,821,000$-38,222,000$-54,586,000$-55,515,000$-32,848,000$-65,742,000
    EBIT$7.35M$-59,618,000$32.97M$-32,633,000$-42,886,000$-59,780,000$-39,253,000$-38,226,000$-53,964,000$-54,268,000$-31,403,000$-64,911,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SDGR

    Government Contracts

    Gov Obligations (TTM)
    $352555
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    N/A
    Active Awards
    5
    New Awards (TTM)
    3
    Avg Remaining Term
    2.8 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N91025P00459Department of Health and Human ServicesNational Institutes of Health$145000Sep 29, 2025
    75F40125P00201Department of Health and Human ServicesFood and Drug Administration$108875Sep 2, 2025
    75N95025P00379Department of Health and Human ServicesNational Institutes of Health$24000Sep 4, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    TD Cowen lifts target for Schrödinger stock to USD 31.00

    TD Cowen has raised its price target for Schrödinger (SDGR) stock to $31.00 from $20.00, citing the company's platform combining molecular discovery software with drug-discovery operations. Schrödinger's stock has seen...

    ad-hoc-news.de•10/15/26•Bullish

    How Schrodinger Inc. (SDGR) Affects Rotational Strategy Timing

    This article analyzes Schrodinger Inc. (SDGR) using AI models to provide institutional trading strategies. It highlights weak near and mid-term sentiment but a strong long-term outlook...

    Stock Traders Daily•10/13/26•Neutral

    TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Raises Target Price to $31

    TD Cowen has reiterated its Buy rating for Schrodinger (SDGR.US) and increased the price target to $31. This update reflects the firm's continued confidence in the company's prospects.

    Moomoo•10/13/26•Bullish

    SDGR Maintained by BMO Capital -- Price Target Raised to $30.00

    BMO Capital analyst Gary Nachman maintained an "Outperform" rating for Schrodinger (SDGR) and raised the price target from $24.00 to $30.00. While the analyst rating is positive...

    GuruFocus•10/12/26•Bullish

    Schrodinger Inc (SDGR) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 72/100

    Schrodinger Inc (SDGR) stock rose 3.4% to $27.28, but its GF Value of $24.08 indicates it is 13.3% overvalued. Despite a strong GF Score of 72/100, driven by a perfect momentum rank...

    GuruFocus•10/9/26•Somewhat-Bearish

    SDGR Valuation and Fair Value

    P/E
    -22.1x
    P/FCF
    -14.8x
    P/B
    5.9x
    See GNG's fair value

    SDGR Profitability: Margins, ROIC and FCF

    Gross margin
    56.9%
    Operating margin
    -70.6%
    Net margin
    -21.0%
    ROE
    -16.2%
    FCF margin
    -50.3%
    FCF yield
    -6.7%

    SDGR Competitors

    CompanyTicker
    BioLife Solutions IncBLFS
    UroGen Pharma LtdURGN
    LeMaitre Vascular IncLMAT
    Surgery Partners IncSGRY
    Vera Therapeutics IncVERA
    Mineralys Therapeutics, Inc. Common StockMLYS
    Inspire Medical Systems IncINSP
    Galapagos NV ADRGLPG

    Sector: Healthcare

    SDGR Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    0
    Buy
    5
    Hold
    2
    Sell
    0
    Strong Sell
    0

    SDGR Bull Case vs Bear Case

    Bull case

    • 71.4% of SDGR's analyst ratings are Buy or Strong Buy.

    Bear case

    • SDGR has a -21.0% net profit margin.

    SDGR Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    21.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.52
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About SDGR

    Does SDGR pay dividends?

    Schrodinger Inc (SDGR) does not currently pay a regular dividend.

    What is SDGR's market cap?

    Schrodinger Inc (SDGR) has a market capitalization of $1.87B with a current stock price of $25.89.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In